The antibacterial medicine sales in Italy from 2024 to 2028 show a mild declining trend, with per capita spending dropping from USD 18.6 in 2024 to USD 18.1 in 2028. Compared to the baseline year of 2023, the data signifies a steady decrease, with an average yearly downward change (CAGR) expected over the five-year span.

Future trends to watch for include:

Emerging antibiotic resistance influencing government policies and pharmaceutical development.
Potential technological advancements in antibiotic formulations and delivery methods.
Public health initiatives and their impact on prescribing patterns.